Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308502 | 12530850 | 2 | F | 201602 | 20160920 | 20160706 | 20160922 | PER | US-TAKEDA-2016MPI006048 | TAKEDA | 49.24 | YR | F | Y | 0.00000 | 20160922 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308502 | 12530850 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | N | 21602 | INJECTION | ||||||||
| 125308502 | 12530850 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 3 | SS | POMALYST | POMALIDOMIDE | 1 | Oral | 4 MG, QD | N | 0 | 4 | MG | CAPSULE | QD | |||||
| 125308502 | 12530850 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, UNK | N | 0 | 10 | MG | |||||||
| 125308502 | 12530850 | 5 | C | COLACE | DOCUSATE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 6 | C | CHANTIX | VARENICLINE TARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 7 | C | MULTIVITAMINS | VITAMINS | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 8 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 10 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 11 | C | MORPHINE | MORPHINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125308502 | 12530850 | 12 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125308502 | 12530850 | 1 | Plasma cell myeloma |
| 125308502 | 12530850 | 2 | Product used for unknown indication |
| 125308502 | 12530850 | 3 | Plasma cell myeloma |
| 125308502 | 12530850 | 4 | Plasma cell myeloma |
| 125308502 | 12530850 | 5 | Product used for unknown indication |
| 125308502 | 12530850 | 6 | Product used for unknown indication |
| 125308502 | 12530850 | 7 | Product used for unknown indication |
| 125308502 | 12530850 | 8 | Product used for unknown indication |
| 125308502 | 12530850 | 9 | Product used for unknown indication |
| 125308502 | 12530850 | 10 | Product used for unknown indication |
| 125308502 | 12530850 | 11 | Product used for unknown indication |
| 125308502 | 12530850 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125308502 | 12530850 | HO |
| 125308502 | 12530850 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125308502 | 12530850 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125308502 | 12530850 | 1 | 201602 | 201602 | 0 | |
| 125308502 | 12530850 | 3 | 201602 | 201602 | 0 | |
| 125308502 | 12530850 | 4 | 201403 | 201601 | 0 |